High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors
Sequential GemDMC-carboplatin/etoposide with or without ifosfamide shows outcomes that exceed the anticipated results in multiply, poor-risk relapsed GCT. Bevacizumab did not improve outcomes. See related commentary by Kollmannsberger et al., p. 257.
Authors
- Peter F. Thall (ORCID: https://orcid.org/0000-0002-7293-529X)
- Börje S. Andersson (ORCID: https://orcid.org/0000-0003-4761-0220)
- Matthew T. Campbell (ORCID: https://orcid.org/0000-0003-1915-4491)
- Shi‐Ming Tu (ORCID: https://orcid.org/0000-0003-0015-2111)
- Andrew Johns (ORCID: https://orcid.org/0000-0001-9821-8662)
- Irtiza Sheikh
- Muzaffar H. Qazilbash (ORCID: https://orcid.org/0000-0003-2876-2886)
- Amishi Y. Shah (ORCID: https://orcid.org/0000-0002-9007-0621)
- Jeremy Ramdial (ORCID: https://orcid.org/0000-0002-8984-3420)
- Roland L. Bassett (ORCID: https://orcid.org/0000-0002-4534-2042)
- Yago L. Nieto (ORCID: https://orcid.org/0000-0001-6034-8939)
- Terri Lynn Shigle (ORCID: https://orcid.org/0000-0002-1322-9555)
- John Kent Lin (ORCID: https://orcid.org/0000-0003-2490-4453)
- Ala Abudayyeh (ORCID: https://orcid.org/0000-0002-5813-6299)
- Louis L. Pisters (ORCID: https://orcid.org/0000-0002-9226-6062)
- John C. Araujo (ORCID: https://orcid.org/0000-0001-9361-3364)
- John F. Ward (ORCID: https://orcid.org/0000-0001-6027-8774)
- Elizabeth J. Shpall (ORCID: https://orcid.org/0000-0003-3947-4126)
- Alison Gulbis (ORCID: https://orcid.org/0000-0003-1921-9152)
- Uday Popat (ORCID: https://orcid.org/0000-0002-7592-2224)
- J. Li (ORCID: https://orcid.org/0000-0001-9260-5776)
- José A. Karam (ORCID: https://orcid.org/0000-0001-7697-9591)
- Lance C. Pagliaro (ORCID: https://orcid.org/0000-0002-4209-3394)
- David C. Rice (ORCID: https://orcid.org/0000-0002-7422-1522)
- Jean‐Nicolas Vauthey (ORCID: https://orcid.org/0000-0003-4921-5427)
- M. J. Barnett
- Jianbo Wang (ORCID: https://orcid.org/0000-0002-2056-639X)
- Roy B. Jones
- Wayne L. Hofstetter (ORCID: https://orcid.org/0000-0002-4865-2783)
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Clinical Cancer Research
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1158/1078-0432.ccr-25-1917
- Citations
- 1
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01